Informations sur le produit
- (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-a-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- (Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- 2-(dibutylamino)-1-{(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethanol
- 2-Dibutylamino-1-[2,7-dichloro-9-[1-(4-chlorophenyl)meth-(Z)-ylidene]-9H-fluoren-4-yl]ethanol
- 9H-Fluorene-4-methanol, 2,7-dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-, (9Z)-
- 9H-Fluorene-4-methanol, 2,7-dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-, (Z)-
- Benflumelol
- dl-Benflumelol
Lumefantrine is a drug that belongs to the class of antimalarial drugs. It is used for the treatment of malaria caused by Plasmodium falciparum, and has been shown to be effective against chloroquine-resistant strains. Lumefantrine inhibits polymerase chain reaction by binding to the β subunit of DNA polymerase, thereby preventing mRNA transcription. The rate constant for lumefantrine was calculated using data from environmental stressors such as heat and cold, and from long-term toxicity studies in rats. Lumefantrine has also been shown to have cardiac effects through its ability to inhibit the activity of α1-acid glycoprotein. This drug inhibits p-glycoprotein (Pgp), which is an ATP-dependent efflux pump located on the cell membrane that pumps out drugs from cells. Pgp inhibitors are useful in combination with other chemotherapeutic agents, such as doxorubicin or vincristine
Propriétés chimiques
Question d’ordre technique sur : 3D-FL24956 Lumefantrine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages